New call-to-action
New call-to-action
New call-to-action

Genetic Therapy and PWS — Researcher Fireside Chat [2019 CONFERENCE VIDEO]

In this video, Drs. Stormy Chamberlain and Jim Resnick discuss the current landscape of PWS genetic therapy, and the feasibility of this therapy.

Gene therapies for PWS have the potential to provide transformative treatments but much is still unknown in regards to the feasibility of a successful treatment. In this 53-minute video, Drs. Stormy Chamberlain and Jim Resnick give a brief overview of PWS genetics, describe the current landscape of PWS genetic therapy, and discuss the feasibility of this therapy. This is followed by questions from the audience. Click below to watch the video. If you're short on time, scroll down for time stamps to find the portions you're most interested in.


Presentation Summary With Timestamps

1:56 Every person with PWS has a copy of chromosome 15 that is intact (that came from mom).

  • All genetic subtypes of PWS have the PWS region genes present but silenced

3:00 Genetic Approaches for PWS:

  • Gene ‘replacement’ seeks to add active PWS genes to cells
  • Gene activation seeks to ‘turn on’ the PWS genes tha are present, but silenced

3:39 PWS Genetics – its Complicated!

  • Unlike other disorders caused by a single gene or protein, in PWS we have a lot going on!

4:20 Feasibility Questions for Genetic Therapy of PWS (list is in presentation)

6:15 Takeaways from Genetic Therapy Meeting

  • There has been promising first steps that have shown encouraging potential for PWS
  • Excellent resources are being developed to help answer our feasibility questions
  • There are additional resources needed
  • We need to start with the end game in mind – what are we looking for when we turn the genes on?

8:04 Stormy Chamberlain, University of Connecticut

  • Researches PWS, Angelman and Dupe15 using iPS cells
  • Develops iPS cells that can also be shared with other researchers and labs
  • Looks mainly at neurons to look at gene regulation
  • Trying to understand why mom’s copy gets silenced and how to turn it on

14:08 Jim Resnick, University of Florida

  • Developing a mouse model to assess gene therapy in PWS
  • PWS may be a good candidate for gene therapy – everyone has a perfectly good copy of the maternally inherited chromosome that is just not working – if we can activate these genes, there may be therapeutic value
  • In development, certain things have to happen at certain times – what will happen if you put the genes back too late? Will it still be helpful?
  • SNORD116 gene deletions – have many of the same traits as PWS. Suggests this one gene is very important. Dr. Resnick is looking to re-establish SNORD116 in a mouse model and then determine WHEN this needs to happen in order to see benefit.

24:25 Begins Q&A with the Audience

New Call-to-action

Topics: Research

Susan Hedstrom


Susan Hedstrom is the Executive Director for the Foundation for Prader-Willi Research. Passionate about finding treatments for PWS, Susan joined FPWR in 2009 shortly after her son, Jayden, was diagnosed with Prader-Willi Syndrome. Rather than accepting PWS as it has been defined, Susan has chosen to work with a team of pro-active and tireless individuals to accelerate PWS research in order to change the future of PWS. Inspired by her first FPWR conference and the team of researchers that were working to find answers for the syndrome, she joined the FPWR team in 2010 and led the development of the One SMALL Step walk program. Under Susan’s leadership, over $15 million has been raised for PWS related research.